Clinicians surveyed note the benefits of palliative care for people with ALS, along with barriers to its integration into ...

The experimental ALS treatment usnoflast exhibited promising signs of slowed functional decline and improved breathing in a ...

Brainstorm Cell Therapeutics plans to launch a Phase 3b trial to test NurOwn against a placebo in about 200 people with mild ...

That’s according to data announced by NurOwn’s developer Brainstorm Cell Therapeutics, which reports that NurOwn may have improved patients’ survival odds as only about 10% of people with ALS survive ...